However, the specific mechanisms by which PEDF activates auditory hair cells and spiral ganglion cells in the treatment of inner ear diseases are still mostly unknown, and further research and clinical trials are needed to verify its safety and efficacy. Here, SERPINF1 is linked to inner ear disorder.